Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation01:37

Neural Regulation

43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades.

Cancer genomics & proteomics·2026
Same author

Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines.

Cancer genomics & proteomics·2026
Same author

Boron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach.

British journal of cancer·2026
Same author

ULK1-driven autophagy modulation alters tumor-promoting pathways in triple-negative breast cancer.

Medical oncology (Northwood, London, England)·2026
Same author

Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells.

Scandinavian journal of immunology·2026
Same author

Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation.

BMC cancer·2026

Related Experiment Video

Updated: Mar 8, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.5K

Proteomic studies associated with Parkinson's disease.

Murat Kasap1, Gurler Akpinar1, Aylin Kanli1

  • 1a Department of Medical Biology/DEKART Proteomics Laboratory , Kocaeli University Medical School , Kocaeli , Turkey.

Expert Review of Proteomics
|February 7, 2017
PubMed
Summary
This summary is machine-generated.

Proteomics research in Parkinson's disease (PD) offers insights into cellular dynamics but has limited diagnostic success. Integrating proteomics with other omics data is crucial for early PD diagnosis and treatment.

Keywords:
Parkinson’s diseaseanimal modelscellular modelsmitochondrial impairmentneurodegenerationneurotoxinsproteomics

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Related Experiment Videos

Last Updated: Mar 8, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.5K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genomics

Background:

  • Parkinson's disease (PD) affects over 1-2% of individuals over 65.
  • Understanding PD etiology is key for developing new treatments.
  • Proteomics provides real-time cellular information, unlike genomics or transcriptomics.

Purpose of the Study:

  • To review and evaluate the current proteomics literature on Parkinson's disease.
  • To connect past findings with present knowledge to guide future research directions.
  • To highlight the contributions of various proteomic studies to PD research.

Main Methods:

  • Literature search conducted using PubMed and Web of Science.
  • Inclusion of studies utilizing human samples, model organisms, and cell lines.
  • Review of selected publications to assess their impact on PD understanding.

Main Results:

  • Proteomic studies have shown limited success in PD diagnosis, monitoring, and progression assessment.
  • A vast body of literature exists, necessitating a comprehensive evaluation.
  • Current proteomic approaches alone are insufficient for clinical application.

Conclusions:

  • A global systems biology approach with novel models is required for PD research.
  • Future research must integrate proteomics with other omics data.
  • Integration aims to improve early diagnosis and therapeutic strategies for PD.